About Indivior
Indivior is a company based in Richmond Hill (United States) founded in 2014.. The company has 1,050 employees as of December 31, 2024. Indivior has completed 1 acquisition, including Opiant Pharmaceuticals. Indivior offers products and services including Addiction Recovery Treatments. Indivior operates in a competitive market with competitors including Ethypharm, Braeburn, Cessation Therapeutics, Amygdala Neurosciences and Aelis Farma, among others.
- Headquarter Richmond Hill, United States
- Employees 1050 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Indivior Plc
-
Annual Revenue
$1.19 B8.69as on Dec 31, 2024
-
Net Profit
$2 M0as on Dec 31, 2024
-
EBITDA
$314 M26.1as on Dec 31, 2024
-
Latest Funding Round
-
Investors
NIH
& 1 more
-
Employee Count
1050
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Indivior
Indivior is a publicly listed company on the NASDAQ with ticker symbol INDV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Indivior
Indivior offers a comprehensive portfolio of products and services, including Addiction Recovery Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medications aimed at supporting recovery from addiction and behavioral issues
Unlock access to complete
Unlock access to complete
Leadership Team
75 people
Sales and Marketing
28 people
Senior Team
22 people
Clinical Team
17 people
Finance and Accounting
15 people
Operations Team
12 people
Software Development Team
12 people
Head Team
11 people
Unlock access to complete
Funding Insights of Indivior
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Grant - Indivior | Valuation |
investors |
|
| Mar, 2015 | Amount | Debt – Venture - Indivior | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Indivior
Indivior has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH and Athyrium Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Indivior
Indivior has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Opiant Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapeutics for addictive and eating disorders are developed.
|
2005 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Indivior
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Indivior Comparisons
Competitors of Indivior
Indivior operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ethypharm, Braeburn, Cessation Therapeutics, Amygdala Neurosciences and Aelis Farma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Long-acting therapies for opioid addiction and chronic pain are developed.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapy based vaccines to manage addictions
|
|
| domain | founded_year | HQ Location |
Therapies for substance use disorders are developed by Amygdala Neurosciences.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule drugs targeting CB1 receptor for CNS diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Indivior
Frequently Asked Questions about Indivior
When was Indivior founded?
Indivior was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Indivior located?
Indivior is headquartered in Richmond Hill, United States. It is registered at Richmond Hill, Georgia, United States.
How many employees does Indivior have?
As of Dec 31, 2024, the latest employee count at Indivior is 1,050.
What is the annual revenue of Indivior?
Annual revenue of Indivior is $1.19B as on Dec 31, 2024.
What does Indivior do?
Indivior was founded in 2014 and is headquartered in Richmond Hill, United States. Operations focus on the pharmaceutical sector, where drugs for addiction treatment are developed and commercialized. The portfolio consists of buprenorphine formulations, including sublingual films, tablets, and combinations with naloxone, all indicated for opioid substance abuse management. Activities span research, development, and market distribution in this specialized therapeutic area.
Who are the top competitors of Indivior?
Indivior's top competitors include Ethypharm, Amygdala Neurosciences and Aelis Farma.
What products or services does Indivior offer?
Indivior offers Addiction Recovery Treatments.
Is Indivior publicly traded?
Yes, Indivior is publicly traded on NASDAQ under the ticker symbol INDV.
How many acquisitions has Indivior made?
Indivior has made 1 acquisition, including Opiant Pharmaceuticals.
Who are Indivior's investors?
Indivior has 2 investors. Key investors include NIH, and Athyrium Capital Management.
What is Indivior's ticker symbol?
The ticker symbol of Indivior is INDV on NASDAQ.